In this instalment of Robert MacNeill’s column, he explores the fascinating manifestations of the phenomenon that we see in bioanalytical LC–MS calibration curves.
Metabolomics is defined as the identification and quantification of metabolic products in a biological system. As part of this Spotlight, we explore the recent advances in target and untargeted metabolomics and review the use of metabolomics in drug development and precision medicine.
Metabolomics expert Martin Giera (Head of the Metabolomics Group at the Leiden University Medical Center) tells us about some of the latest metabolomics developments. Is it possible that activity metabolomics could shape our future understanding of biology? Learn more.
In this interview, Ann Van Eeckhaut (Vrije Universiteit Brussel, Belgium) discusses her current focus in metabolomics research and the challenges her research group are currently facing.
Trajan Scientific and Medical (Melbourne, Australia) has listed its hemaPEN® blood microsampling device with the US FDA as Class I for therapeutic and in vitro diagnostic use.
Brendan Griffin (University College Cork, Ireland) discusses his work in early drug development in this interview with Bioanalysis Zone. Brendan talks about the most common challenges faced as well as key trends in the field of developability.
After an uncertain start to 2020, the organizing committee of the Workshop in Recent Issues in Bioanalysis (WRIB; 15–29 June 2020) converted the meeting that was due to take place in Phoenix (AZ, USA) to a virtual platform. In this round-up, we summarize some of our highlights from attending the virtual conference.
A simple sweat collection and analysis device from Penn State University (PA, USA) and Xiangtan University (Xiangtan, China) could assist healthcare professionals with diagnosising and monitoring disease progression by measuring biomarkers, such as pH and glucose.
White Paper – EBF recommendation on practical management of critical reagents for antidrug antibody ligand-binding assays
In this White Paper from Bioanalysis, the authors discuss the European Bioanalysis Forum’s recommendations for critical reagents (CR) for immunogenicity assays. They present the requirements for CR and describe the consequences of introducing new lots of CR to immunogenicity assays.
In this interview, Timothy Garrett (University of Florida, FL, USA) discusses the use of MS in his research, some of the key differences between imaging MS and LC–MS and gives some top tips for method development.